common cold
Information
- Disease name
- common cold
- Disease ID
- DOID:10459
- Description
- "An upper respiratory tract disease which involves inflammation of the mucous membranes of the nose, throat, eyes, and eustachian tubes with watery then purulent discharge. This is an acute contagious disease caused by rhinoviruses, human parainfluenza viruses, human respiratory syncytial virus, influenza viruses, adenoviruses, enteroviruses, or metapneumovirus." [url:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=common%20cold]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06005337 | Active, not recruiting | N/A | Supporting Parents to Choose Wisely | June 5, 2023 | March 31, 2025 |
NCT00032500 | Completed | Phase 2 | Evaluation of Echinacea for the Common Cold | September 2001 | May 2004 |
NCT00065715 | Completed | Phase 3 | Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo) | September 2003 | April 2013 |
NCT00231218 | Completed | Phase 3 | Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers | January 2006 | March 2006 |
NCT00299559 | Completed | Phase 1 | Kinetics of Etheric Oils, Smart Textiles vs. Ointment | March 2006 | August 2006 |
NCT00358774 | Completed | Phase 1/Phase 2 | Efficacy of Homeopathic Nasal Formulation for Management of Experimental Rhinoviral Colds | March 2001 | March 2002 |
NCT00378144 | Completed | Phase 4 | Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold | January 2007 | March 2008 |
NCT00394914 | Completed | Phase 2 | Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) | August 2006 | April 2007 |
NCT00405509 | Completed | The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years | October 2006 | January 2009 | |
NCT00448981 | Completed | N/A | Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial | November 2006 | June 2008 |
NCT00452270 | Completed | Phase 3 | Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold | March 2007 | April 2007 |
NCT00480194 | Completed | Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM) | December 2006 | January 2008 | |
NCT00552981 | Completed | N/A | Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) | November 2007 | April 2009 |
NCT00617318 | Completed | Phase 3 | Pomegranate Products for Prevention of Common Cold | January 2007 | June 2007 |
NCT00655031 | Completed | Phase 2 | Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection | April 2008 | July 2008 |
NCT00762476 | Completed | Phase 2 | Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses | August 2008 | November 2008 |
NCT00778648 | Completed | N/A | Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms | September 2008 | July 2009 |
NCT00963443 | Completed | Phase 3 | Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold | September 2009 | March 2012 |
NCT04144491 | Completed | N/A | Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda | September 16, 2019 | May 30, 2020 |
NCT03901846 | Completed | N/A | Duration of ColdZyme® II | May 7, 2019 | July 25, 2019 |
NCT00029211 | Completed | Phase 3 | A Trial of Echinacea in Children | April 2000 | March 2003 |
NCT04326309 | Completed | Audio Data Collection for Identification and Classification of Coughing | March 25, 2020 | January 24, 2022 | |
NCT04533906 | Completed | N/A | Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses | August 4, 2020 | November 10, 2020 |
NCT04681001 | Completed | N/A | Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers | December 20, 2020 | August 30, 2021 |
NCT04943575 | Completed | N/A | Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI) | June 1, 2021 | January 30, 2022 |
NCT05002179 | Completed | Phase 4 | Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections | November 20, 2020 | May 29, 2021 |
NCT05034328 | Completed | Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK) | February 14, 2022 | November 3, 2022 | |
NCT05126407 | Completed | A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage | December 17, 2021 | January 20, 2022 | |
NCT05269290 | Completed | Phase 3 | Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections | September 23, 2021 | July 15, 2022 |
NCT05269329 | Completed | Phase 2 | Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection | April 26, 2021 | October 26, 2021 |
NCT05273619 | Completed | Phase 3 | Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection | May 23, 2022 | July 29, 2022 |
NCT05556148 | Completed | Phase 4 | Otrivine: Quality of Life (QoL) Impact in a Real-World Setting | November 7, 2022 | December 20, 2022 |
NCT05640570 | Completed | Phase 2 | The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elderly With Qi-deficiency Constitution (CCJWBT): A Pragmatic Randomized Controlled Trial | February 21, 2022 | August 8, 2022 |
NCT05819190 | Completed | N/A | Testing the Efficacy in Adults With Cold of HEalsea Rescue* | December 14, 2022 | January 31, 2023 |
NCT05819203 | Completed | N/A | BАbykids Spray In Common Cold | February 13, 2023 | May 16, 2023 |
NCT05960318 | Completed | Post Market Clinical Follow-Up Study - Medical Device KalobaNaso | May 8, 2023 | July 31, 2023 | |
NCT06106880 | Completed | Phase 1 | Alleviation of Common Cold Symptoms | May 25, 2022 | June 16, 2023 |
NCT01033526 | Completed | Phase 4 | Symptomatic Treatment of Common Cold Symptoms | October 2005 | June 2007 |
NCT01046136 | Completed | Phase 2 | Mucinex Exploratory Cold Study | December 2009 | |
NCT01062360 | Completed | Phase 3 | Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine | December 23, 2005 | May 14, 2007 |
NCT01092039 | Completed | N/A | Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold | March 2010 | April 2011 |
NCT01158326 | Completed | Phase 3 | Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu | August 2010 | November 2011 |
NCT01277081 | Completed | Phase 2 | Effect of Paracetamol on the Common Cold | October 2010 | December 2010 |
NCT01332578 | Completed | Phase 4 | A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies | May 2011 | June 2011 |
NCT01361399 | Completed | Phase 3 | Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold | November 30, 2004 | May 28, 2005 |
NCT01459952 | Completed | Phase 3 | A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold | November 2011 | May 2012 |
NCT01465009 | Completed | Phase 4 | Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold | November 2003 | March 2005 |
NCT01466348 | Completed | Phase 4 | Effects of a Common Cold Treatment on Cognitive Function | February 2011 | April 2011 |
NCT01488604 | Completed | N/A | A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold | January 2012 | May 2012 |
NCT01651715 | Completed | Phase 1/Phase 2 | Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections | September 2012 | August 2013 |
NCT01669603 | Completed | N/A | Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR) | August 2012 | June 2016 |
NCT01677702 | Completed | N/A | Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization | March 2011 | October 2011 |
NCT01677715 | Completed | N/A | Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System | August 2011 | March 2012 |
NCT01686646 | Completed | Phase 3 | Effects of Two Doses of a Common Cold Treatment on Alertness | November 2011 | November 2012 |
NCT01728090 | Completed | Phase 4 | Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections | October 2009 | May 2010 |
NCT01823640 | Completed | Phase 1 | Experimental Human Rhinovirus Infection | March 2013 | June 2014 |
NCT01883440 | Completed | Phase 2 | Glucose Oxidase as Treatment Against Common Cold | January 2013 | September 2013 |
NCT01883453 | Completed | Phase 2 | A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold | January 2013 | September 2013 |
NCT01944631 | Completed | Phase 4 | Iota-Carrageenan Nasal Spray in Common Cold | September 2013 | March 2014 |
NCT02174653 | Completed | Phase 3 | Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) | March 2014 | August 2016 |
NCT02246166 | Completed | Phase 4 | The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza. | January 2015 | February 2015 |
NCT02438579 | Completed | N/A | Hypertonic Saline Nasal Irrigation and Gargling for the Common Cold. | August 2014 | October 2015 |
NCT02451163 | Completed | Phase 2 | DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly | September 2014 | March 2016 |
NCT02479750 | Completed | N/A | Evaluation of ColdZyme® on Experimentally Induced Common Cold. | March 23, 2016 | July 25, 2016 |
NCT02522949 | Completed | N/A | Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold | March 2013 | June 2013 |
NCT02535442 | Completed | Nasal Swab Study to Explore the Nasal Microbia | August 2015 | June 2016 | |
NCT02644018 | Completed | Phase 3 | Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. | January 2016 | May 2016 |
NCT02660489 | Completed | Phase 2 | Effect of OC459 on the Response to Rhinovirus Challenge in Asthma | January 2015 | February 2018 |
NCT02679807 | Completed | N/A | Effect of Probiotic on Rhinovirus Induced Colds | February 2016 | April 2018 |
NCT02778100 | Completed | Phase 1 | A Study of Nasal Glucagon in Participants With a Common Cold | March 2013 | April 2013 |
NCT02822287 | Completed | Phase 3 | Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough | February 2016 | March 2016 |
NCT02832362 | Completed | Phase 1 | Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants | June 11, 2016 | July 18, 2016 |
NCT02957136 | Completed | N/A | Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department | December 8, 2016 | April 30, 2018 |
NCT02981147 | Completed | Phase 4 | PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough | March 14, 2017 | March 30, 2018 |
NCT03005067 | Completed | Phase 2 | To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold | December 29, 2016 | June 7, 2017 |
NCT03154515 | Completed | Phase 4 | Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults | January 2010 | October 2014 |
NCT03189537 | Completed | Phase 3 | Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections | October 3, 2010 | October 10, 2011 |
NCT03191097 | Completed | Phase 3 | Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. | August 2014 | March 2015 |
NCT03206346 | Completed | Phase 3 | Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o. | January 2012 | August 2013 |
NCT03309995 | Completed | N/A | The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold | December 1, 2017 | September 24, 2018 |
NCT03415243 | Completed | Phase 1 | To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers | March 1, 2018 | March 29, 2018 |
NCT03474887 | Completed | Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care | March 30, 2018 | December 20, 2021 | |
NCT03683108 | Completed | Phase 3 | Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infancy | December 2015 | March 2018 |
NCT03794804 | Completed | N/A | Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold | January 28, 2019 | June 26, 2019 |
NCT03831763 | Completed | N/A | Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth Spray | January 25, 2018 | June 5, 2018 |
NCT05070650 | Not yet recruiting | Phase 3 | Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold | September 20, 2024 | April 30, 2025 |
NCT06278324 | Recruiting | N/A | Effectiveness of a Nasal Spray on Viral Respiratory Infections | January 26, 2024 | July 2024 |
NCT05244148 | Recruiting | N/A | Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects | November 25, 2021 | April 30, 2023 |
NCT06315400 | Recruiting | Phase 4 | Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections | December 19, 2023 | December 31, 2025 |
NCT05944705 | Recruiting | Commercially Available Cannabis Products for Immune Support | November 1, 2023 | December 1, 2024 | |
NCT01257542 | Terminated | Phase 4 | Acute Cough Study In Children | December 2010 | March 2011 |
NCT01964885 | Terminated | Phase 3 | Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections | October 2013 | May 2014 |
NCT03339726 | Terminated | Phase 2 | Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold | November 30, 2017 | April 16, 2018 |
NCT04073511 | Unknown status | N/A | Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold | September 16, 2019 | December 31, 2020 |
NCT04672850 | Unknown status | N/A | The Effect of Probiotic and Zinc Supplementation on the Common Cold | January 27, 2021 | November 2022 |
NCT00993759 | Unknown status | Phase 2 | Efficacy Study of A Lotion to Prevent Common Colds | August 2009 | December 2009 |
NCT04368520 | Unknown status | Phase 2 | Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection | June 2020 | May 2022 |
NCT00940836 | Unknown status | Phase 3 | Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome | June 2009 | |
NCT03070314 | Withdrawn | Phase 4 | Echinaforce Junior Bioavailability Trial | February 20, 2017 | June 30, 2018 |
NCT02656888 | Withdrawn | Phase 3 | Efficacy and Safety of Irlanda-1-Association on the Treatment of Common Cold in Children | June 2019 | September 2020 |
NCT02656914 | Withdrawn | Phase 3 | Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold | June 2019 | September 2020 |
NCT01938144 | Withdrawn | Phase 3 | Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America | April 2016 | November 2016 |
NCT00967759 | Withdrawn | Phase 3 | Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old |
- Disase is a (Disease Ontology)
- DOID:974
- Cross Reference ID (Disease Ontology)
- ICD10CM:J00
- Cross Reference ID (Disease Ontology)
- ICD9CM:460
- Cross Reference ID (Disease Ontology)
- MESH:D003139
- Cross Reference ID (Disease Ontology)
- NCI:C34500
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:195648002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0009443
- Exact Synonym (Disease Ontology)
- acute coryza
- Exact Synonym (Disease Ontology)
- acute nasopharyngitis
- Exact Synonym (Disease Ontology)
- acute rhinitis
- Exact Synonym (Disease Ontology)
- Acute viral rhinopharyngitis
- Exact Synonym (Disease Ontology)
- Nasopharyngitis - acute
- Exact Synonym (Disease Ontology)
- Nasopharyngitis, acute
- Exact Synonym (Disease Ontology)
- rhino-sinusitis
- MedGen concept unique identifier (MedGen Concept name)
- C0009443
- MedGen unique identifier (MedGen Concept name)
- 3179
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003139